Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized crossover PK and endometrial effects study of daily subcutaneous progesterone 25 mg versus 50 mg
ChiCTR2500102276Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of progesterone (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Histopathological changes of endometrial cycle and Pharmacokinetic parameters. Planned start May 2025; status: not yet recruiting.
02
Drugs
progesterone
Beyond the preview
Go deeper on ChiCTR2500102276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102276.